Evidence, not personal-use guidance
This page explains research terminology and documentation. It does not provide medical advice, dosing, injection, administration or a recommendation to obtain or use any substance.
What is NAD+?
Nicotinamide adenine dinucleotide (NAD+) is a cellular redox cofactor, not a peptide, but it is frequently grouped with peptide research products online.
Search results often combine research papers, supplier descriptions and personal claims. Those sources answer different questions. A paper can describe a mechanism or study outcome; only a batch-specific analytical record can describe the tested sample.
Identity and naming
The distinction matters for search and testing: NAD+ is a dinucleotide cofactor with different chemistry, analytical methods and degradation pathways from peptides.
Useful records state the exact material, expected molecular characteristics, batch code, sample identifier and form. See peptide sequence and molecular weight for why a familiar name is not enough.
What the research base shows
A large basic-science literature covers redox metabolism, enzymes and age-related biology. Research on NAD metabolism, precursors or cellular pathways does not automatically establish outcomes for every method of supplying NAD+.
Evidence should be sorted by level: biochemical or cell studies, animal models, observational human data, controlled trials and regulatory evidence. A result at one level should not be silently rewritten as a conclusion at another.
Analytical and COA questions
Use methods appropriate to nucleotides and redox state. Confirm whether a report measures NAD+, NADH, related degradation products or total NAD species; a generic peptide purity template is unsuitable.
- Does the report name this exact molecular form?
- Does the sample or batch code match the container?
- Are identity, peak-area purity and quantitative content reported separately?
- Can the laboratory and report number be independently traced?
Use the field-by-field COA guide before relying on a headline percentage.
What this page cannot establish
It cannot establish that any commercial material is genuine, sterile, safe, legally supplied or suitable for a particular purpose. Regulatory status and authorised uses can change and vary by country; consult the MHRA Products registry and other relevant official sources.
Frequently asked questions
Is NAD+ a peptide?
No. It is a dinucleotide cofactor, although it is often marketed beside peptides.
Are NAD+ and NADH the same?
No. They are oxidised and reduced forms with distinct analytical significance.
Related external reading:
- analytical testing overviewexternal · supplier educational page
External links are editorial references, not endorsements.
Research sources
- PubMed literature search: NAD+.
- ClinicalTrials.gov search: NAD+.
- IUPAC peptide terminology.
- ICH Q2(R2): analytical procedure validation.
Search links are provided because the literature and regulatory status can change. Sources were checked on 19 September 2026.